AAAAAA
Results:
1-19
|
Results: 19
Authors:
Durinx, C
Neels, H
Van der Auwera, JC
Naelaerts, K
Scharpe, S
De Meester, I
Citation: C. Durinx et al., Reference values for plasma dipeptidyl-peptidase IV activity and iheir association with other laboratory parameters, CLIN CH L M, 39(2), 2001, pp. 155-159
Authors:
Antczak, C
De Meester, I
Bauvois, B
Citation: C. Antczak et al., Transmembrane proteases as disease markers and targets for therapy, J BIOL REG, 15(2), 2001, pp. 130-139
Authors:
Antczak, C
De Meester, I
Bauvois, B
Citation: C. Antczak et al., Ectopeptidases in pathophysiology, BIOESSAYS, 23(3), 2001, pp. 251-260
Authors:
Lambeir, AM
Proost, P
Durinx, C
Bal, G
Senten, K
Augustyns, K
Scharpe, S
Van Damme, J
De Meester, I
Citation: Am. Lambeir et al., Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidaseIV reveals a striking selectivity within the chemokine family, J BIOL CHEM, 276(32), 2001, pp. 29839-29845
Authors:
Lambeir, AM
Durinx, C
Proost, P
Van Damme, J
Scharpe, S
De Meester, I
Citation: Am. Lambeir et al., Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion, FEBS LETTER, 507(3), 2001, pp. 327-330
Authors:
van West, D
Monteleone, P
Di Lieto, A
De Meester, I
Durinx, C
Scharpe, S
Lin, AH
Maj, M
Maes, M
Citation: D. Van West et al., Lowered Serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa, EUR ARCH PS, 250(2), 2000, pp. 86-92
Authors:
Durinx, C
Lambeir, AM
Bosmans, E
Falmagne, JB
Berghmans, R
Haemers, A
Scharpe, S
De Meester, I
Citation: C. Durinx et al., Molecular characterization of dipeptidyl peptidase activity in serum - Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides, EUR J BIOCH, 267(17), 2000, pp. 5608-5613
Authors:
Proost, P
Menten, P
Struyf, S
Schutyser, E
De Meester, I
Van Damme, J
Citation: P. Proost et al., Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78 beta into a most efficient monocyte attractant and CCR1 agonist, BLOOD, 96(5), 2000, pp. 1674-1680
Authors:
Korom, S
De Meester, I
Coito, A
Graser, E
Volk, HD
Schwemmle, K
Scharpe, S
Kupiec-Weglinski, JW
Citation: S. Korom et al., Immunomodulatory influence of CD26 dipeptidylpeptidase IV during acute andaccelerated rejection, LANG ARCH S, 1999, pp. 241-245
Authors:
Zhang, XY
De Meester, I
Lambeir, AM
Dillen, L
Van Dongen, W
Esmans, EL
Haemers, A
Scharpe, S
Claeys, M
Citation: Xy. Zhang et al., Study of the enzymatic degradation of vasostatin I and II and their precursor chromogranin A by dipeptidyl peptidase IV using high-performance liquidchromatography electrospray mass spectrometry, J MASS SPEC, 34(4), 1999, pp. 255-263
Authors:
Maes, M
Lin, AH
Bonaccorso, S
Vandoolaeghe, E
Song, C
Goossens, F
De Meester, I
DeGroote, J
Neels, H
Scharpe, S
Janca, A
Citation: M. Maes et al., Lower activity of serum peptidases in abstinent alcohol-dependent patients, ALCOHOL, 17(1), 1999, pp. 1-6
Authors:
De Meester, I
Korom, S
Van Damme, J
Scharpe, S
Citation: I. De Meester et al., CD26, let it cut or cut it down, IMMUNOL TOD, 20(8), 1999, pp. 367-375
Authors:
Schols, D
Proost, P
Struyf, S
Wuyts, A
De Meester, I
Scharpe, S
Van Damme, J
De Clercq, E
Citation: D. Schols et al., CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity (vol 39, pg 175, 1998), ANTIVIR RES, 40(3), 1999, pp. 189-190
Authors:
Korom, S
De Meester, I
Schmidbauer, G
Pratschke, J
Brendel, MD
Durinx, C
Schwemmle, K
Haemers, A
Scharpe, S
Kupiec-Weglinski, JW
Citation: S. Korom et al., Specific inhibition of CD26/DPP IV enzymatic activity in allograft recipients: Effects on humoral immunity, TRANSPLAN P, 31(1-2), 1999, pp. 778-778
Authors:
Korom, S
De Meester, I
Coito, AJ
Graser, E
Pratschke, J
Konig, S
Grimm, H
Volk, HD
Scharpe, S
Kupiec-Weglinski, JW
Citation: S. Korom et al., CD26/DPP IV-mediated modulation of acute rejection, TRANSPLAN P, 31(1-2), 1999, pp. 873-873
Authors:
Belyaev, A
Zhang, XM
Augustyns, K
Lambeir, AM
De Meester, I
Vedernikova, I
Scharpe, S
Haemers, A
Citation: A. Belyaev et al., Structure-activity relationship of diaryl phosphonate esters as potent irreversible dipeptidyl peptidase IV inhibitors, J MED CHEM, 42(6), 1999, pp. 1041-1052
Authors:
Struyf, S
Proost, P
Schols, D
De Clercq, E
Opdenakker, G
Lenaerts, JP
Detheux, M
Parmentier, M
De Meester, I
Scharpe, S
Van Damme, J
Citation: S. Struyf et al., CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3, J IMMUNOL, 162(8), 1999, pp. 4903-4909
Authors:
Proost, P
Struyf, S
Schols, D
Opdenakker, G
Sozzani, S
Allavena, P
Mantovani, A
Augustyns, K
Bal, G
Haemers, A
Lambeir, AM
Scharpe, S
Van Damme, J
De Meester, I
Citation: P. Proost et al., Truncation of macrophage-derived chemokine by CD26/dipeptidyl-peptidase IVbeyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction, J BIOL CHEM, 274(7), 1999, pp. 3988-3993
Authors:
Bauvois, B
De Meester, I
Dumont, J
Rouillard, D
Zhao, HX
Bosmans, E
Citation: B. Bauvois et al., Constitutive expression of CD26/dipeptidylpeptidase IV on peripheral bloodB lymphocytes of patients with B chronic lymphocytic leukaemia, BR J CANC, 79(7-8), 1999, pp. 1042-1048
Risultati:
1-19
|